Synergy CHC amends credit agreement, adds EBITDA covenant, issues 3M-share warrant at $0.00001

Synergy CHC Corp.

Amortization revised: $175k quarterly payments in Q3/Q4 2026, $525k Jan 2027, then $350k quarterly.
Interest step-up: if less than $10M equity raised by Sep 30, 2026, Applicable Margin increases 2% from Oct 1, 2026.
New EBITDA covenant: min $500k Q2 2026, $1M Q3 2026; max senior net leverage 20:1 for Dec 2025.
Issued 3M-share warrant to lender at $0.00001/sh, exercisable only upon qualified default; 19.9% limit until approval.
Mandatory prepayment: first $6M equity proceeds retained, next $4M apply to term loan, excess above $10M subject to prepayment.

item 1.01 item 2.03 item 3.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Synergy CHC Corp. amended Second Amendment with ACP Agency, LLC (effective 2026-03-24).

Action: amendment
Agreement: credit facility
Counterparty: ACP Agency, LLC
Effective: 2026-03-24

Exact text from the filing

On March 24, 2026, Synergy CHC Corp. (the “Company”) entered into a second amendment (the “Second Amendment”) to its term loan credit agreement

View on SEC.gov

299 material agreements filed in the last 30 days. Browse all material agreements →

Synergy CHC Corp. filing history →

Source: SEC EDGAR

accession 0001213900-26-034072

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.